These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 7583077

  • 1. Decreased axial and peripheral bone density in patients taking long-term warfarin.
    Philip WJ, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS.
    QJM; 1995 Sep; 88(9):635-40. PubMed ID: 7583077
    [Abstract] [Full Text] [Related]

  • 2. Vitamin K deficiency from long-term warfarin anticoagulation does not alter skeletal status in male rhesus monkeys.
    Binkley N, Krueger D, Engelke J, Suttie J.
    J Bone Miner Res; 2007 May; 22(5):695-700. PubMed ID: 17295605
    [Abstract] [Full Text] [Related]

  • 3. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US, Akkaya A, Yildiz M, Bircan A, Aksoy Dogan A, Ozturk O.
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density in rural Thai adults living in Khon Kaen province.
    Pongchaiyakul C, Rojroongwasinkul N, Chotmongkol R, Kosulwat V, Charoenkiatkul S, Rajatanavin R.
    J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
    [Abstract] [Full Text] [Related]

  • 5. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U, Teichmann J, Müller-Ladner U, Strunk J.
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [Abstract] [Full Text] [Related]

  • 6. [The effect of a low-dose hydrochlorothiazide therapy on the bone mineral content of the axial and peripheral skeleton].
    Jergas M, Kosow A, Uffmann M, Schmutz G, Böckenförde JB, Glüer CC, Köster O.
    Dtsch Med Wochenschr; 1994 Dec 02; 119(48):1645-52. PubMed ID: 7988364
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density and history of oral contraceptive use.
    Fortney JA, Feldblum PJ, Talmage RV, Zhang J, Godwin SE.
    J Reprod Med; 1994 Feb 02; 39(2):105-9. PubMed ID: 8169923
    [Abstract] [Full Text] [Related]

  • 8. Reduced bone density in children on long-term warfarin.
    Barnes C, Newall F, Ignjatovic V, Wong P, Cameron F, Jones G, Monagle P.
    Pediatr Res; 2005 Apr 02; 57(4):578-81. PubMed ID: 15695604
    [Abstract] [Full Text] [Related]

  • 9. Prediction of bone mineral density of lumbar spine, hip, femoral neck and Ward's triangle by forearm bone mineral density.
    Trivitayaratana W, Trivitayaratana P, Kongkiatikul S.
    J Med Assoc Thai; 2001 Mar 02; 84(3):390-6. PubMed ID: 11460941
    [Abstract] [Full Text] [Related]

  • 10. Should COPD patients be routinely evaluated for bone mineral density?
    Karadag F, Cildag O, Yurekli Y, Gurgey O.
    J Bone Miner Metab; 2003 Mar 02; 21(4):242-6. PubMed ID: 12811630
    [Abstract] [Full Text] [Related]

  • 11. Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli.
    Sugiyama T, Takaki T, Sakanaka K, Sadamaru H, Mori K, Kato Y, Taguchi T, Saito T.
    J Endocrinol; 2007 Jul 02; 194(1):213-22. PubMed ID: 17592035
    [Abstract] [Full Text] [Related]

  • 12. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May 02; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 13. Reduced bone density in patients on long-term warfarin.
    Rezaieyazdi Z, Falsoleiman H, Khajehdaluee M, Saghafi M, Mokhtari-Amirmajdi E.
    Int J Rheum Dis; 2009 Jul 02; 12(2):130-5. PubMed ID: 20374330
    [Abstract] [Full Text] [Related]

  • 14. The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects.
    Obrant KJ, Käkönen SM, Astermark J, Lilja H, Lövgren T, Akesson K, Pettersson K.
    J Bone Miner Res; 1999 Apr 02; 14(4):555-60. PubMed ID: 10234576
    [Abstract] [Full Text] [Related]

  • 15. Comparison of inhibitory effects of warfarin on gamma-carboxylation between bone and liver in rats.
    Hara K, Kobayashi M, Akiyama Y.
    J Bone Miner Metab; 2005 Apr 02; 23(5):366-72. PubMed ID: 16133686
    [Abstract] [Full Text] [Related]

  • 16. Impaired carboxylation of osteocalcin in warfarin-treated patients.
    Menon RK, Gill DS, Thomas M, Kernoff PB, Dandona P.
    J Clin Endocrinol Metab; 1987 Jan 02; 64(1):59-61. PubMed ID: 2878010
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats.
    Simon RR, Beaudin SM, Johnston M, Walton KJ, Shaughnessy SG.
    Thromb Res; 2002 Feb 15; 105(4):353-8. PubMed ID: 12031831
    [Abstract] [Full Text] [Related]

  • 18. Adverse effects of coumarin anticoagulants.
    Pineo GF, Hull RD.
    Drug Saf; 1993 Oct 15; 9(4):263-71. PubMed ID: 8260120
    [Abstract] [Full Text] [Related]

  • 19. Drug-induced Reduction of Gamma Carboxylation in Osteocalcin: What is the Fallback?
    Usman N, Qaseem A, Jayaraj JS, Fathima N, Janapala RN.
    Cureus; 2019 Aug 28; 11(8):e5504. PubMed ID: 31667038
    [Abstract] [Full Text] [Related]

  • 20. Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis.
    Namba S, Yamaoka-Tojo M, Hashikata T, Ikeda Y, Kitasato L, Hashimoto T, Shimohama T, Tojo T, Takahira N, Masuda T, Ako J.
    BBA Clin; 2015 Dec 28; 4():76-80. PubMed ID: 26674156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.